BCM
ISEE

Burrage Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Burrage Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,388,136
Closed -$9.59M – 32
2020
Q4 		$9.59M Sell
1,388,136
-107,379
-7% -$687K 7.31% 4
2020
Q3 		$8.44M Buy
1,495,515
+18,644
+1% +$88.9K 6.66% 4
2020
Q2 		$7.53M Sell
1,476,871
-44,511
-3% -$185K 5.27% 5
2020
Q1 		$4.99M Sell
1,521,382
-130,089
-8% -$760K 4.91% 5
2019
Q4 		$14.2M Buy
+1,651,471
New +$5.9M 9.5% 2

Other funds holding ISEE

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return

Burrage Capital Management's ISEE Position: Q1 2021 in Review

Burrage Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2021, closing a stake of 1,388,136 shares — an estimated $9.59M sold.

Burrage Capital Management first reported a position in ISEE in Q4 2019 and held it in 5 quarters. The position peaked at $14.2M in Q4 2019. 115 funds tracked by Wall St. Rank hold ISEE as of Q1 2021.

  • Burrage Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Burrage Capital Management sold 1,388,136 IVERIC bio, Inc. Common Stock shares in Q1 2021, an estimated $9.59M.
  • Burrage Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
  • Burrage Capital Management's IVERIC bio, Inc. Common Stock position peaked at $14.2M in Q4 2019.
  • 115 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2021.

Based on Burrage Capital Management's 13F filing for Q1 2021, filed 17 May 2021.